The Schools · where founders come from

School of Medicine

UVA’s deepest translation engine — and the largest single source of faculty ventures.

46%of Enterprise Studio faculty ventures
$203M+in NIH awards, FY2025
#36nationally in NIH funding

Overview

Medicine has the most translational capital already in motion: dedicated innovation funds, Virginia’s NIH clinical-translational hub, and a pipeline that feeds the Manning Institute, the Coulter Center, Enterprise Studio and the BioAccelerator.

  • LaunchPad for Diabetes — $1.1M a year; 77 projects, 6 startups, $19M follow-on over 15 years
  • Ivy Biomedical Innovation Fund — about $500K a year, awards requiring a clinical collaborator
  • UVA Cancer Center Accelerating Innovation Fund — about $1M a year
  • iTHRIV pilot translational awards up to $50K
  • FY25 ventures: Avant Genomics, Vasarya, S1P Therapeutics, Stepping In 4 Respect, Nouveau Biosciences